- Motley Fool•yesterday
Biotech stocks are known for their high growth, but they can also be toxic for your portfolio if you don't invest wisely.
- TheStreet.com•2 days ago
SNY has become much stronger since late October; buy here and above $44.
- PR Newswire•2 days agoRegeneron and Sanofi to Present New Data on DUPIXENT® (dupilumab) for Moderate-to-Severe Atopic Dermatitis at Upcoming Medical Congresses
TARRYTOWN, N.Y. and CAMBRIDGE, Mass., Feb. 27, 2017 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that detailed results from the Phase 3 CHRONOS study will be ...
SAN.PA : Summary for SANOFI - Yahoo Finance
Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
|Bid||71.12 x 1000|
|Ask||71.74 x 44000|
|Day's Range||81.76 - 83.29|
|52 Week Range||62.50 - 83.29|
|PE Ratio (TTM)||22.63|
|Dividend & Yield||3.35 (3.93%)|
|1y Target Est||N/A|